Remove 2014 Remove Healthcare Remove Healthcare Provider Remove Specialization
article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The lengthy validation of defossilised organic chemicals and plastics for the healthcare sector will take several years. The path to real zero. located in Brussels.

article thumbnail

Liron Fendell

Cadensee

Liron Fendell is the CEO of Nutritional Growth Solutions, or NGS, that specializes in scientific supplement formulas for children of a small stature. Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. We are seeing a lot of consumer-based healthcare coming from China. Liron Fendell. Show Notes.

Retail 52